Age-related decline in oligodendrogenesis retards white matter repair in mice

Stroke

Volumn 44, Issue 9, 2013, Pages 2573-2578

  Miyamoto, Nobukazu ^a   Pham, Loc Duyen D ^a   Hayakawa, Kazuhide ^a   Matsuzaki, Toshinori ^a   Seo, Ji Hae ^a,b   Magnain, Caroline ^a   Ayata, Cenk ^a   Kim, Kyu Won ^b   Boas, David ^a   Lo, Eng H ^a   Arai, Ken ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Seoul National University   (South Korea)

Author keywords

Aging; Animal model; Cyclic AMP response element binding protein; Oligodendrocyte; White matter diseases

Indexed keywords

CILOSTAZOL; COBALT CHLORIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MYELIN; MYELIN BASIC PROTEIN;

AGE DISTRIBUTION; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEVELOPMENT; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; COGNITIVE DEFECT; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORPUS CALLOSUM; IN VITRO STUDY; IN VIVO STUDY; MALE; MEMORY DISORDER; MOUSE; MYELINATION; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGENESIS; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TISSUE REPAIR; WHITE MATTER; WHITE MATTER INJURY; WORKING MEMORY;

AGING; ANIMAL MODEL; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; OLIGODENDROCYTE; WHITE MATTER DISEASES;

AGING; ANIMALS; ANTIMUTAGENIC AGENTS; CELLS, CULTURED; COBALT; COGNITION DISORDERS; CORPUS CALLOSUM; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISEASE MODELS, ANIMAL; HYPOXIA, BRAIN; LEUKOENCEPHALOPATHIES; MALE; MICE; MICE, INBRED C57BL; MYELIN SHEATH; NEURAL STEM CELLS; NEUROGENESIS; NEUROPROTECTIVE AGENTS;

EID: 84884503312     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001530     Document Type: Article

References (23)

1. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al; American Heart Association Stroke Council; Council on Epidemiology and Prevention; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672-2713.
2. Marini C, Triggiani L, Cimini N, Ciancarelli I, De Santis F, Russo T, et al. Proportion of older people in the community as a predictor of increasing stroke incidence. Neuroepidemiology. 2001;20:91-95.
3. Béjot Y, Rouaud O, Jacquin A, Osseby GV, Durier J, Manckoundia P, et al. Stroke in the very old: incidence, risk factors, clinical features, outcomes and access to resources-a 22-year population-based study. Cerebrovasc Dis. 2010;29:111-121.
4. Lo EH. A new penumbra: transitioning from injury into repair after stroke. Nat Med. 2008;14:497-500.
5. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron. 2010;67:181-198.
6. Kaplan MS, Bell DH. Mitotic neuroblasts in the 9-day-old and 11-monthold rodent hippocampus. J Neurosci. 1984;4:1429-1441.
7. Kuhn HG, Dickinson-Anson H, Gage FH. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci. 1996;16:2027-2033.
8. Walter J, Keiner S, Witte OW, Redecker C. Age-related effects on hippocampal precursor cell subpopulations and neurogenesis. Neurobiol Aging. 2011;32:1906-1914.
9. Asanuma M, Nishibayashi S, Iwata E, Kondo Y, Nakanishi T, Vargas MG, et al. Alterations of cAMP response element-binding activity in the aged rat brain in response to administration of rolipram, a cAMP-specific phosphodiesterase inhibitor. Brain Res Mol Brain Res. 1996;41:210-215.
10. Miyamoto N, Tanaka R, Shimura H, Watanabe T, Mori H, Onodera M, et al. Phosphodiesterase III inhibition promotes differentiation and survival of oligodendrocyte progenitors and enhances regeneration of ischemic white matter lesions in the adult mammalian brain. J Cereb Blood Flow Metab. 2010;30:299-310.
11. Skihar V, Silva C, Chojnacki A, Döring A, Stallcup WB, Weiss S, et al. Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate. Proc Natl Acad Sci USA. 2009;106:17992-17997.
12. Gensert JM, Goldman JE. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron. 1997;19:197-203.
13. Doucette JR, Jiao R, Nazarali AJ. Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice. Cell Mol Neurobiol. 2010;30:607-629.
14. Sim FJ, Zhao C, Penderis J, Franklin RJ. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci. 2002;22:2451-2459.
15. Tanaka Y, Tanaka R, Liu M, Hattori N, Urabe T. Cilostazol attenuates ischemic brain injury and enhances neurogenesis in the subventricular zone of adult mice after transient focal cerebral ischemia. Neuroscience. 2010;171:1367-1376.
16. Kempermann G, Kuhn HG, Gage FH. Experience-induced neurogenesis in the senescent dentate gyrus. J Neurosci. 1998;18:3206-3212.
17. Lemaire V, Koehl M, Le Moal M, Abrous DN. Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc Natl Acad Sci USA. 2000;97:11032-11037.
18. Charalampopoulos I, Alexaki VI, Tsatsanis C, Minas V, Dermitzaki E, Lasaridis I, et al. Neurosteroids as endogenous inhibitors of neuronal cell apoptosis in aging. Ann N Y Acad Sci. 2006;1088:139-152.
19. Barnett AH, Bradbury AW, Brittenden J, Crichton B, Donnelly R, Homer-Vanniasinkam S, et al. The role of cilostazol in the treatment of intermittent claudication. Curr Med Res Opin. 2004;20:1661-1670.
20. Shinohara Y, Katayama Y, Uchiyama S, Yamaguchi T, Handa S, Matsuoka K, et al; CSPS 2 Group. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised noninferiority trial. Lancet Neurol. 2010;9:959-968.
21. Arai K, Lo EH. Oligovascular signaling in white matter stroke. Biol Pharm Bull. 2009;32:1639-1644.
22. Rage F, Silhol M, Binamé F, Arancibia S, Tapia-Arancibia L. Effect of aging on the expression of BDNF and TrkB isoforms in rat pituitary. Neurobiol Aging. 2007;28:1088-1098.
23. Popa-Wagner A, Buga AM, Kokaia Z. Perturbed cellular response to brain injury during aging. Ageing Res Rev. 2011;10:71-79.